Ana Maria Segura, MD, MPH

Dr. Segura graduated from Universidad Javeriana Medical School, Bogota, Colombia. She completed post-graduate training in Surgical Pathology at the same institution and fellowships in Cytopathology (Harvard Medical School), Gastrointestinal Pathology (Baylor College of Medicine), Cardiovascular Pathology (THI) and a Master's degree in Public Health (Tulane University). She is an Associate Research Investigator at THI and a Clinical Assistant Professor at Baylor College of Medicine. Show full bio

Her main areas of interest are heart failure, ventricular remodeling, transplantation, ventricular assist devices, aortic pathology and electrophysiology. Her work has been published in several peer-reviewed journals and has been presented in multiple national and international conferences.

See Publications

Texas Heart Institute Positions

Interests

  • Heart failure
  • Electrophysiology
  • Ventricular remodeling

Education

  • Undergraduate:

    Universidad Javeriana Medical School, Bogota, Colombia

  • Postgraduate:

    Universidad Javeriana Medical School, Bogota, Colombia

  • Fellowships:

    Harvard Medical School

Honors, Awards and Memberships

Publications

Li, K., Segura, A. M., Sun, J. et al. (2022). Rare delayed cardiac tamponade in a pig after cardiac surgery. Vet Med Sci. https://doi.org/10.1002/vms3.892.
Buja, L. M. and Segura, A. M. (2021). Victor J. Ferrans, MD, PhD (1937-2001). Cardiology. https://doi.org/10.1159/000521084.
Palaskas, N. L., Segura, A., Lelenwa, L. et al. (2021). Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. https://doi.org/10.1002/ejhf.2265.
Yan, J. S., Orecchioni, M., Vitale, F. et al. (2021). Biocompatibility studies of macroscopic fibers made from carbon nanotubes: Implications for carbon nanotube macrostructures in biomedical applications. Carbon 173, 462–476. https://doi.org/10.1016/j.carbon.2020.10.077.
Corporan, D., Segura, A. and Padala, M. (2021). Ultrastructural adaptation of the cardiomyocyte to chronic mitral regurgitation. Front Cardiovasc Med 8, 714774. https://doi.org/10.3389/fcvm.2021.714774.
Monroe, M. N., Zhaorigetu, S., Gupta, V. S. et al. (2020). Extracellular vesicles influence the pulmonary arterial extracellular matrix in congenital diaphragmatic hernia. Pediatr Pulmonol. https://doi.org/10.1002/ppul.24914.
Jeyakumar, N., Etchegaray, M., Henry, J. et al. (2020). The terrible triad of checkpoint inhibition: A case report of myasthenia gravis, myocarditis, and myositis induced by cemiplimab in a patient with metastatic cutaneous squamous cell carcinoma. Case Reports Immunol 2020, 5126717. https://doi.org/10.1155/2020/5126717.
Zhang, Y., Beketaev, I., Segura, A. M. et al. (2020). Contribution of increased expression of Yin Yang 2 to development of cardiomyopathy. Front Mol Biosci 7, 35. https://doi.org/10.3389/fmolb.2020.00035.
Leach, J. P., Heallen, T., Zhang, M. et al. (2017). Hippo pathway deficiency reverses systolic heart failure after infarction. Nature 550, 260–264. https://doi.org/10.1038/nature24045.
Nazeri, A., Ganapathy, A. V., Massumi, A. et al. (2017). Effect of botulinum toxin on inducibility and maintenance of atrial fibrillation in ovine myocardial tissue. Pacing Clin Electrophysiol 40, 693–702. https://doi.org/10.1111/pace.13079.